Alerts will be sent to your verified email
Verify Email
SENORES
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Number of ANDA's Approved
|
81.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
16.92 % | 5.0 % | 8.0 % |
|
Financials
|
|||
|
5 yr Average ROE
|
11.02 % | 21.63 % | 12.89 % |
|
5yr average Equity Multiplier
|
2.25 | 1.32 | 1.39 |
|
5yr Average Asset Turnover Ratio
|
0.3 | 0.84 | 0.86 |
|
5yr Avg Net Profit Margin
|
15.05 % | 19.77 % | 11.15 % |
|
Price to Book
|
4.41 | 7.3 | 3.34 |
|
P/E
|
41.17 | 32.37 | 27.97 |
|
5yr Avg Cash Conversion Cycle
|
-30.87 Days | -102.34 Days | 9.46 Days |
|
Inventory Days
|
46.48 Days | 55.16 Days | 99.1 Days |
|
Days Receivable
|
108.09 Days | 49.8 Days | 66.32 Days |
|
Days Payable
|
255.02 Days | 195.69 Days | 164.9 Days |
|
5yr Average Interest Coverage Ratio
|
4.44 | 108.5 | 30.59 |
|
5yr Avg ROCE
|
10.25 % | 27.48 % | 15.26 % |
|
5yr Avg Operating Profit Margin
|
22.88 % | 27.65 % | 17.29 % |
|
5 yr average Debt to Equity
|
0.83 | 0.0 | 0.14 |
|
5yr CAGR Net Profit
|
126.15 % | 7.08 % | -12.64 % |
|
5yr Average Return on Assets
|
4.54 % | 16.51 % | 9.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
45.8 % | 66.25 % | 69.74 % |
|
Share Pledged by Promoters
|
0.0 | 15.28 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | -4.23 % | 0.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-2.08 % | 3.53 % | 3.19 % |
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|